And
"results using its allogeneic mesenchymal stem cell product candidate remestemcel-L in patients with inflammatory lung disease have been selected for oral presentation at the 2020 International Society of Cell and Gene Therapy (ISCT) annual meeting being held May 28-29, 2020"
Nice!
Ann: Inflammatory Lung Disease Outcomes For Presentation at ISCT, page-2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.81 |
Change
0.288(18.9%) |
Mkt cap ! $2.009B | |||
| Open | High | Low | Value | Volume |
| $1.74 | $1.82 | $1.71 | $20.83M | 11.74M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2649 | $1.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.82 | 65978 | 9 |
View Market Depth
| Last trade - 13.16pm 14/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |